Viking Therapeutics has multiple promising drugs in its portfolio that could generate billions in future revenue. Approval of VK2735 and VK2809 could lead to a surge in the stock's value.

Relief Therapeutics Reports 2024 Financial Results and Provides Corporate Update 10-Apr-2025 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely ...

Tempest Therapeutics (TPST) announced that the company plans to explore a full range of strategic alternatives to advance its clinical stage programs. Strategic alternatives under consideration ...

Bearish flow noted in Soleno Therapeutics (SLNO) with 4,468 puts trading, or 3x expected. Most active are Apr-25 55 puts and Apr-25 70 calls, with total volume in those strikes near 4,300 contracts.

In this article, we are going to take a look at where Intellia Therapeutics, Inc. (NASDAQ:NTLA) stands against other stocks under $10 that will triple. As we delve into the discussion on stocks ...

WATERTOWN, Mass., April 09, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader ...

Kymera Therapeutics (KYMR) announced the appointment of Noah Goodman, M.B.A., as Chief Business Officer. Goodman brings a wealth of diverse experience in the life sciences industry to Kymera and ...

In a report released yesterday, Mohit Bansal from Wells Fargo maintained a Buy rating on Travere Therapeutics (TVTX – Research Report), with a price target of $27.00. The company’s shares ...

In a report released today, Joseph Stringer from Needham maintained a Buy rating on Stoke Therapeutics (STOK – Research Report), with a price target of $22.00. The company’s shares closed ...

Chardan initiated coverage of Palvella Therapeutics (PVLA) with a Buy rating and $50 price target citing the potential of its QTORIN topical rapamycin gel as an “attractive” treatment in mTOR ...

His father, Clinton Thompson, expressed outrage over a malfunctioning crosswalk light at the time of the accident. "My son was crossing the crosswalk [the] light was not operating on the south ...

7 analysts have shared their evaluations of Voyager Therapeutics VYGR during the recent three months, expressing a mix of bullish and bearish perspectives. The table below provides a concise ...